CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Corline Biomedical's project focuses on validating Renaparin®, a novel compound designed to protect kidney cells during transplantation. This technology aims to reduce organ rejection and improve transplant outcomes, addressing the critical shortage of available organs.
This project will validate the safety and efficacy of Corline Biomedical’s pharmaceutical compound Renaparin®, a novel cell replacement technology used to coat the lining of the blood vessels of kidneys prior to transplantation.
Donor kidneys lack natural blood flow while awaiting transplantation.
This can lead to ischemia (a shortage of oxygen and glucose supply to the kidney tissue).
When connected to the recipient’s blood flow, this in turn leads to ischemia reperfusion injury (IRI).
Given t…
CORLINE BIOMEDICAL AB
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.